Product Information
FIORICET 50-300-40 MG CAPSULE is a brand (anda) product labeled by Actavis Pharma, Inc., priced at $8.8237 per EA under NDC 52544008001. Its NADAC has been published 664 times since Dec 5, 2013.
FDA first approved this application on Nov 16, 2009. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Butalbital, Acetaminophen, and Caffeine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300; 50; 40 mg/1; mg/1; mg/1
Manufacturer
Actavis Pharma, Inc.NDC
52544008001
Classification
Brand (ANDA)
Dosage Form
CAPSULE
Route
ORAL
Effective Date
1/1/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA040885FDA Approved
11/16/2009
TE Code
AA
On Market Since
7/29/2013
Pharmacological Classes
Price Statistics
The NADAC for FIORICET 50-300-40 MG CAPSULE has been published 664 times since Dec 5, 2013, and over the history we have for it it has risen 303.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.8237 per EA |
|---|---|
| All-time high | $8.8237 (Aug 19, 2026) |
| All-time low | $2.1862 (Dec 5, 2013) |
| 52-week high | $8.8237 |
| 52-week low | $8.0655 |
| Median price | $5.2088 |
| Average price | $5.4113 |
| Largest weekly change | +30.0% (Oct 8, 2014) |
| Weeks tracked | 664 |
| Tracking since | Dec 5, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FIORICET 50-300-40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FIORICET 50-300-40 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $8.8237 per EA (NDC 52544008001), effective Aug 19, 2026.
How has the price of FIORICET 50-300-40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FIORICET 50-300-40 MG CAPSULE has risen 303.6%. It has been tracked across 664 weekly CMS publications since Dec 5, 2013.
What are the highest and lowest recorded NADAC prices for FIORICET 50-300-40 MG CAPSULE?
Since Dec 5, 2013, the NADAC for FIORICET 50-300-40 MG CAPSULE has ranged from a low of $2.1862 (Dec 5, 2013) to a high of $8.8237 (Aug 19, 2026), with a median of $5.2088 per EA.
Are there cheaper alternatives to FIORICET 50-300-40 MG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE, is $0.3161 per EA — about 96% below FIORICET 50-300-40 MG CAPSULE.
Who manufactures FIORICET 50-300-40 MG CAPSULE?
FIORICET 50-300-40 MG CAPSULE (NDC 52544008001) is labeled by Actavis Pharma, Inc., and CMS classifies it as a brand (anda) product.